$ONCT Oncternal Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Oncternal Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Oncternal Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Oncternal Therapeutics, Inc. for free.

CIK Number: 0001260990
IRS Number: 621715807
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ONCT
Company Address: 12230 EL CAMINO REAL SUITE 300 SAN DIEGO 92130
Phone number: 901-523-9700
Former name: GTX INC /DE/, date of change: 2003-08-22

Market Capitalization: $86.92M
Prev close: $5.58
Average Daily Volume: 79,148
Days Low: $5.45
Year Low: $5.00
Year High: $11.19

Oncternal Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
AKER HAZEL MLegal Counsel4,28423,905shares bought: 9,299 / shares sold: 0 STRONG BUYMar 18 20202 months ago
BILINSKY IGORChief Business Officer00Mar 18 20202 months ago
BREITMEYER JAMES BChief Executive Officer255,5911,426,198shares bought: 277,868 / shares sold: 0 STRONG BUYMar 18 20202 months ago
Hsu Frank J.Chief Medical Officer00Mar 18 20202 months ago
Kaufmann Gunnar F.Chief Scientific Officer00Mar 18 20202 months ago
VINCENT RICHARD GChief Financial Officer40,794227,631shares bought: 48,988 / shares sold: 0 STRONG BUYMar 18 20202 months ago

View all Oncternal Therapeutics, Inc. insiders.

Oncternal Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 18 2020ONCTOncternal Therapeu ...BREITMEYER JAMES BChief Executive Off ...Option ExerciseA3.3366,890222,74466,890
Mar 18 2020ONCTOncternal Therapeu ...VINCENT RICHARD GChief Financial Off ...Option ExerciseA3.3335,120116,95035,120
Mar 18 2020ONCTOncternal Therapeu ...Kaufmann Gunnar F.Chief Scientific Of ...Option ExerciseA3.3314,26047,48614,260
Mar 18 2020ONCTOncternal Therapeu ...Hsu Frank J.Chief Medical Offic ...Option ExerciseA3.3316,28054,21216,280
Mar 18 2020ONCTOncternal Therapeu ...BILINSKY IGORChief Business Offi ...Option ExerciseA3.3312,69042,25812,690
Mar 18 2020ONCTOncternal Therapeu ...AKER HAZEL MLegal CounselOption ExerciseA3.3311,08036,89611,080
Jan 09 2020GTXIOncternal Therapeu ...BREITMEYER JAMES BChief Executive Off ...Option ExerciseA4.1322,00090,86022,000
Dec 23 2019GTXIOncternal Therapeu ...Cho ManDirectorOption ExerciseA4.1130,000123,30030,000
Sep 16 2019GTXIOncternal Therapeu ...Wills Robert JamesDirectorOption ExerciseA5.7630,000172,80030,000
Sep 16 2019GTXIOncternal Therapeu ...THEUER CHARLESDirectorOption ExerciseA5.7630,000172,80030,000
Sep 16 2019GTXIOncternal Therapeu ...Nakanishi XinDirectorOption ExerciseA5.7630,000172,80030,000
Sep 16 2019GTXIOncternal Therapeu ...Liu YanjunDirectorOption ExerciseA5.7630,000172,80030,000
Sep 16 2019GTXIOncternal Therapeu ...LARUE WILLIAM RDirectorOption ExerciseA5.7630,000172,80030,000
Sep 16 2019GTXIOncternal Therapeu ...KISNER DANIEL LDirectorOption ExerciseA5.7630,000172,80030,000
Sep 16 2019GTXIOncternal Therapeu ...HALE DAVID FDirectorOption ExerciseA5.7640,000230,40040,000

View all Oncternal Therapeutics, Inc. insider transactions.